Due to the presence of neutrophilic inflammation in the course of bacterial lung infection with S. pneumoniae (13), we wondered whether treatment with the CXCR1/2 antagonist would affect pneumococcal pneumonia. Here, CXCR1 is linked to pneumococcal pneumonia.